Adaptimmune Therapeutics PLC ADR (ADAP) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Wed June 16th, 2021

- 12:00
  AnalysisAdaptimmune Therapeutics: Still The TCR Leader, And With Major Upcoming CatalystsSeeking Alpha

Wed June 2nd, 2021

- 05:32
  AnalysisASCO 2021: A Plethora Of Cancer Therapeutic Investment IdeasSeeking Alpha

Fri May 7th, 2021

- 13:29
  EarningsAnalysisAdaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha

Mon March 29th, 2021

- 20:03
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  IPOAnalysisAchilles Therapeutics Aims For $176 Million U.S. IPOSeeking Alpha

Mon March 15th, 2021

- 17:09
  IPOAnalysisIPO Update: Instil Bio Proposes $250 Million IPO TermsSeeking Alpha

Thu February 25th, 2021

- 19:07
  EarningsAnalysisAdaptimmune Therapeutics PLC (ADAP) CEO Adrian Rawcliffe on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha

Mon February 22nd, 2021

- 20:13
  AnalysisOur Take On Adaptimmune TherapeuticsSeeking Alpha

Thu December 10th, 2020

- 13:00
  AnalysisAdaptimmune: Clear Leader In TCR Therapies Targeting Solid Tumors, Speculative InvestmentSeeking Alpha

Tue November 10th, 2020

- 23:59
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisAdaptimmune Therapeutics (ADAP) Presents At SITC Virtual Annual Meeting 2020 - SlideshowSeeking Alpha

Fri November 6th, 2020

- 16:01
  EarningsAnalysisAdaptimmune Therapeutics PLC (ADAP) Q3 2020 Earnings Call TranscriptThe Motley Fool
- 03:18
  EarningsAnalysisAdaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha

Wed September 16th, 2020

- 00:22
  AnalysisAdaptimmune Therapeutics: Mega ProfitabilitySeeking Alpha

Fri September 11th, 2020

- 14:53
  AnalysisAdaptimmune Therapeutics (ADAP) Investor Presentation - SlideshowSeeking Alpha

Sat August 22nd, 2020

- 12:12
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisStocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng MotorsSeeking Alpha

Sat August 15th, 2020

- 12:30
  AnalysisStocks To Watch: Walmart, Target, Kandi And Gold vs. BitcoinSeeking Alpha

Sun August 9th, 2020

- 11:51
  EarningsAnalysisAdaptimmune Therapeutics plc (ADAP) CEO Adrian Rawcliffe on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha

Thu August 6th, 2020

- 23:01
  EarningsAnalysisAdaptimmune Therapeutics PLC (ADAP) Q2 2020 Earnings Call TranscriptThe Motley Fool

Mon June 1st, 2020

- 16:51
  AnalysisWhy Adaptimmune Therapeutics Stock Sank and Then Quickly Rebounded TodayThe Motley Fool

Fri May 29th, 2020

- 18:20
  AnalysisHere's Why Adaptimmune Therapeutics Is Rocketing Higher TodayThe Motley Fool
- 17:03
  Adaptimmune Therapeutics (ADAP) Presents At ASCO 2020 - SlideshowSeeking Alpha

SPY$395.63-6.2%

QQQ$315.85-8.5%

DOW$64.140.94%

NVAX$173.01-3.8%

SPY$395.63-6.2%

QQQ$315.85-8.5%

DOW$64.140.94%

NVAX$173.01-3.8%

About Developer Contact